mic polymer that protects them from osmotic lysis and that serves as an anchor for cellular components, including virulence factors (10) . PG biogenesis is the target of many antibiotics, but increasing resistance is rendering many such antibiotics ineffective (6) . Recently, MurJ (formerly MviN) has been shown essential for PG biogenesis in Escherichia coli and has been proposed to function as the flippase that translocates the PG precursor lipid II across the cytoplasmic membrane (3, 7 To investigate whether YtgP is the E. coli MurJ ortholog, I tested whether YtgP complements MurJ-depleted E. coli cells. The algorithm ParAlign, which is more sensitive than BLASTP (8) , showed that there are several YtgP paralogs in B. subtilis (EpsK, SpoVB, YfkQ, and YabM); therefore, I chose the YtgP from an organism encoding a single ortholog, namely, Spy_0390 (GenBank accession no. AAK33429.1) from Streptococcus pyogenes. First, the Spy_0390 gene from S. pyogenes M6 strain HSC5 was amplified using PCR primers Sp5ORF0390 (5Ј-GCCTCGACAGAAAAAAAACAACTGA CACAAGAAGAATTG) and Sp3ORF0390 (5Ј-CCATGCCA GCCTAATTTCTGACGAAGGCGACT), and the blunt-ended product was introduced into StuI-digested pCA24N(-gfp) (4) to yield pSpyMurJ1, which produces Spy_0390 under the control of an isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible promoter as a hybrid protein with an N-terminal MRGS-His 6 -TDP ALRA peptide fused to its second amino acid and a Cterminal GLCGR peptide fused to its last amino acid. For controls, ASKA collection (4) plasmids pCA24N(-gfp) and its derivative carrying the E. coli murJ were used and renamed pCA24Not and pEcMurJ1, respectively. Chloramphenicol (20 g/ml) was used for plasmid selection.
Vectors pCA24Not, pEcMurJ1, and pSpyMurJ1 were introduced into E. coli strain NR1152, which produces MurJ in the presence of arabinose but lyses when grown in the absence of arabinose because of the depletion of MurJ (7). To quantify complementation, efficiency of plating values of overnight cultures were determined by plating serial dilutions on Luria-Bertani (LB) medium alone and LB medium containing either arabinose or IPTG (Table 1 ). An efficiency of plating value of 1 was assigned to E. coli NR1152(pCA24Not) plated on LB containing arabinose. As expected, strain NR1152 (pCA24Not) only grew with arabinose. E. coli NR1152 (pEcMurJ1) grew with arabinose or IPTG; it also grew on LB owing to leaky expression of E. coli murJ from the plasmid (4). E. coli NR1152(pSpyMurJ1) grew well with arabinose and not without arabinose, but IPTG fully restored growth, albeit it yielded smaller colonies than NR1152(pEcMurJ1) did. The lower rate of growth of E. coli NR1152(pSpyMurJ1) compared to NR1152(pEcMurJ1) is likely caused by lower expression of the streptococcal protein owing to differences in codon usage between the two bacteria, since the streptococcal sequence includes several codons rarely used in E. coli. Moreover, passage of E. coli NR1152(pSpyMurJ1) through medium containing high levels of IPTG selected for mutations in the IPTG-inducible promoter region of pSpyMurJ1 that restored wild-type colony size. Restoration of wild-type growth was proven to be linked to these promoter mutations in the plasmid; thus, once appropriate levels of Spy_0390 gene expression are achieved, Spy_0390 protein complements fully.
These results indicate that Spy_0390 and E. coli MurJ are functional homologs, so they suggest that YtgP orthologs, which are widely spread among gram-positive bacteria, likely function as PG lipid II flippases. As expected from such function, YtgP is essential in S. pneumoniae and Staphylococcus aureus (9, 11) . Notably, YtgP is not essential in B. subtilis probably because of redundancy among the aforementioned paralogs (5). The cross-phylum complementation reported here has two implications important for the development of MurJ inhibitors. First, because lipid II in E. coli differs from that of S. pyogenes (10) , MurJ likely recognizes features in lipid II that are common in both phyla, namely, the undecaprenylpyrophosphoryl disaccharide. Second, it might be possible to find inhibitors of these putative lipid II flippases that will be broad-spectrum antibiotics.
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